Skip to main content
SpringerLink
Log in

Nuclear Cardiology and Coronavirus Disease 2019 (COVID-19) Pandemic

  • Chapter
  • First Online:
Nuclear Cardiology

  • 886 Accesses

Abstract

The world changed in few months after the emergence of the novel coronavirus disease 2019 (COVID-19), caused by a beta coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The transmission of COVID-19 is most commonly secondary to the exposure to infected droplets. Prolonged exposure to an infected person is related to an increase in the transmission risk. Asymptomatic and presymptomatic carriers can transmit SARS-CoV-2. Cardiovascular risk factors and chronic cardiovascular conditions are prevalent among patients affected by COVID- 19 and associated with adverse outcomes. Besides that COVID-19 has also demonstrated damage to the cardiovascular system with several manifestations, such as myocardial injury, acute myocardial infarction, heart failure, Takotsubo syndrome, arrhythmias, myocarditis, and shock. In this chapter we review the relationship of COVID-19 and cardiovascular risk factors and diseases. Best practices, strategies, precautions, and experiences to manage the risks of COVID-19 in nuclear cardiology departments are addressed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, et al. First case of 2019 novel coronavirus in the United States. N Engl J Med. 2020;382(10):929–36.

    Article  CAS  Google Scholar 

  2. Oliveira GMM, de Pinto FJ. COVID-19: a matter close to the heart. Int J Cardiovasc Sci. 2020;33(3):199–202.

    Google Scholar 

  3. Nishiga M, Wang DW, Han Y, Lewis DB, Wu JC. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat Rev Cardiol [Internet]. 2020:1–16. Available from: http://www.nature.com/articles/s41569-020-0413-9

  4. Berlin DA, Gulick RM, Martinez FJ. Severe Covid-19. N Engl J Med. 2020:1–10.

    Google Scholar 

  5. Sethuraman N, Jeremiah SS, Ryo A. Interpreting diagnostic tests for SARS-CoV-2. JAMA – J Am Med Assoc. 2020;2019:2019–21.

    Google Scholar 

  6. Chu DK, Akl EA, Duda S, Solo K, Yaacoub S, Schünemann HJ, et al. Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis. Lancet. 2020:1973–87.

    Google Scholar 

  7. Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Pathophysiology PHC. Transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA – J Am Med Assoc. 2020;2019:1–13.

    Google Scholar 

  8. Wölfel R, Corman VM, Guggemos W, Seilmaier M, Zange S, Müller MA, et al. Virological assessment of hospitalized patients with COVID-2019. Nature [Internet]. 2020;581(7809):465–9. Available from: https://doi.org/10.1038/s41586-020-2196-x

  9. Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, et al. Remdesivir for the treatment of Covid-19 – preliminary report. N Engl J Med. 2020;

    Google Scholar 

  10. RECOVERY Collaborative Group, Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, et al. Dexamethasone in Hospitalized Patients with Covid-19 – Preliminary Report. N Engl J Med [Internet]. 2020:1–11. Available from: http://www.ncbi.nlm.nih.gov/pubmed/32678530

  11. da Silva Costa IB, Bittar CS, Rizk SI, de Araújo Filho AE, Santos KAQ, Machado TIV, et al. The heart and COVID-19: what cardiologists need to know. Arq Bras Cardiol. 2020;114(5):805–16.

    Article  Google Scholar 

  12. Maria G, Oliveira M, De Pinto FJ. COVID-19: a matter close to the heart. Int J Cardiovasc Sci. 2020:2–5.

    Google Scholar 

  13. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet [Internet]. 2020;395(10229):1054–62. Available from: https://doi.org/10.1016/S0140-6736(20)30566-3

  14. Lang JP, Wang X, Moura FA, Siddiqi HK, Morrow DA, Bohula EA. A current review of COVID-19 for the cardiovascular specialist. Am Heart J [Internet]. 2020;226:29–44. Available from: https://doi.org/10.1016/j.ahj.2020.04.025

    Article  CAS  Google Scholar 

  15. Corrales-Medina VF, Musher DM, Shachkina S, Chirinos JA. Acute pneumonia and the cardiovascular system. Lancet [Internet]. 2013;381(9865):496–505. Available from: https://doi.org/10.1016/S0140-6736(12)61266-5

  16. Musher DM, Abers MS, Corrales-Medina VF. Acute infection and myocardial infarction. N Engl J Med [Internet]. 2019;380(2):171–6. Available from: http://www.nejm.org/doi/10.1056/NEJMra1808137

    Article  CAS  Google Scholar 

  17. Pedro SDS, Carla F, De BF, Bretas C, Scaramello V. Challenges in pharmacological Management of Cardiovascular Diseases in Covid-19: do benefits outweigh risks? Int J Cardiovasc Sci. 2020;33(4):404–11.

    Google Scholar 

  18. Prieto-Lobato A, Ramos-Martínez R, Vallejo-Calcerrada N, Corbí-Pascual M, Córdoba-Soriano JG. A case series of stent thrombosis during the COVID-19 pandemic. JACC Case Reports [Internet]. 2020;2(9):1291–6. Available from: https://doi.org/10.1016/j.jaccas.2020.05.024

    Article  Google Scholar 

  19. Loghin C, Chauhan S, Lawless SM. Pseudo-acute myocardial infarction in a young COVID-19 patient. JACC Case Reports [Internet]. 2020;2(9):1284–8. Available from: https://doi.org/10.1016/j.jaccas.2020.04.015

    Article  Google Scholar 

  20. Buja LM, Wolf D, Zhao B, Akkanti B, McDonald M, Lelenwa L, et al. The emerging spectrum of cardiopulmonary pathology of the coronavirus disease 2019 (COVID-19): report of 3 autopsies from Houston, Texas, and review of autopsy findings from other United States cities. Cardiovasc Pathol [Internet]. 2020;48:107233. Available from: https://doi.org/10.1016/j.carpath.2020.107233

    Article  CAS  Google Scholar 

  21. Puntmann VO, Carerj ML, Wieters I, Fahim M, Arendt C, Hoffmann J, et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol [Internet]. 2020;2019:1–9. Available from: https://jamanetwork.com/journals/jamacardiology/fullarticle/2768916

  22. Nai Fovino L, Cademartiri F, Tarantini G. Subclinical coronary artery disease in COVID-19 patients. Eur Heart J Cardiovasc Imaging. 2020:1–2.

    Google Scholar 

  23. Solomon MD, McNulty EJ, Rana JS, Leong TK, Lee C, Sung S-H, et al. The Covid-19 pandemic and the incidence of acute myocardial infarction. N Engl J Med [Internet]. 2020;NEJMc2015630. Available from: http://www.nejm.org/doi/10.1056/NEJMc2015630

  24. De Filippo O, D’Ascenzo F, Angelini F, Bocchino PP, Conrotto F, Saglietto A, et al. Reduced rate of hospital admissions for ACS during Covid-19 outbreak in northern Italy. N Engl J Med [Internet]. 2020;383(1):88–9. Available from: http://www.nejm.org/doi/10.1056/NEJMc2015630

    Article  Google Scholar 

  25. Marijon E, Karam N, Jost D, Perrot D, Frattini B, Derkenne C, et al. Out-of-hospital cardiac arrest during the COVID-19 pandemic in Paris, France: a population-based, observational study. Lancet Public Heal. 2020;2667(20):1–7.

    Google Scholar 

  26. Freudenberg LS, Paez D, Giammarile F, Cerci JJ, Modiselle M, Pascual TNB, et al. Global impact of COVID-19 on nuclear medicine departments: an international survey in April 2020. J Nucl Med [Internet]. 2020;(April):jnumed.120.249821. Available from: http://jnm.snmjournals.org/lookup/doi/10.2967/jnumed.120.249821

  27. Piccolo R, Bruzzese D, Mauro C, Aloia A, Baldi C, Boccalatte M, et al. Population trends in rates of percutaneous coronary revascularization for acute coronary syndromes associated with the COVID-19 outbreak. Circulation. 2020:2035–7.

    Google Scholar 

  28. Nappi C, Megna R, Acampa W, Assante R, Zampella E, Gaudieri V, et al. Effects of the COVID-19 pandemic on myocardial perfusion imaging for ischemic heart disease. Eur J Nucl Med Mol Imaging. 2020;

    Google Scholar 

  29. Scrima G, Amico MD, Bertuccio G, Canavese G, De SP. Safety measures and clinical outcome of nuclear cardiology department during Covid-19 lockdown pandemic: northern Italy experience. J Nucl Cardiol [Internet]. 2020. Available from: https://doi.org/10.1007/s12350-020-02286-y

  30. Czernin J, Fanti S, Meyer PT, Allen-Auerbach M, Hacker M, Sathekge M, et al. Nuclear medicine operations in the times of COVID-19: strategies, precautions, and experiences. J Nucl Med. 2020;61(5):626–9.

    Article  CAS  Google Scholar 

  31. Skali H, Murthy VL, Al-Mallah MH, Bateman TM, Beanlands R, Better N, et al. Guidance and best practices for nuclear cardiology laboratories during the coronavirus disease 2019 (COVID-19) pandemic: an Information Statement from ASNC and SNMMI. J Nucl Cardiol [Internet]. 2020;27(3):1022–9. Available from: https://doi.org/10.1007/s12350-020-02203-3

    Article  Google Scholar 

  32. Albano D, Bertagna F, Bertoli M, Bosio G, Lucchini S, Motta F, et al. Incidental findings suggestive of COVID-19 in asymptomatic patients undergoing nuclear medicine procedures in a high-prevalence region. J Nucl Med. 2020;61(5):632–6.

    Article  CAS  Google Scholar 

  33. Parikh KD, Ramaiya NH, Kikano EG, Tirumani SH, Pandya H, Stovicek B, et al. COVID-19 pandemic impact on decreased imaging utilization: a single institutional experience. Acad Radiol [Internet]. 2020;(6):1–10. Available from: https://doi.org/10.1016/j.acra.2020.06.024

  34. Skali H, Murthy VL, Al-Mallah MH, Bateman TM, Beanlands R, Better N, et al. Guidance and best practices for nuclear cardiology laboratories during the coronavirus disease 2019 (COVID-19) pandemic: an information Statement from ASNC and SNMMI. J Nucl Med. 2020;2019:jnumed.120.246686.

    Google Scholar 

  35. European Society of cardiology. ESC guidance for the diagnosis and management of CV disease during the COVID-19 pandemic. Eur Heart J. 2020:1–115.

    Google Scholar 

  36. Driggin E, Madhavan MV, Bikdeli B, Chuich T, Laracy J, Bondi-Zoccai G, et al. Cardiovascular considerations for patients, health care workers, and health systems during the coronavirus disease 2019 (COVID-19). Pandemic. J Am Coll Cardiol [Internet]. 2020;2019. Available from: https://doi.org/10.1016/j.jacc.2020.03.031

  37. Mesquita CT, Oliveira A, Seixas FL, Paes A. Infodemia, fake news and medicine: science and the quest for truth. Int J Cardiovasc Sci. 2020;33(3):203–5.

    Google Scholar 

  38. Wang X, Ferro EG, Zhou G, Hashimoto D, Bhatt DL. Association between universal masking in a health care system and SARS-CoV-2 positivity among health care workers. JAMA [Internet]. 2020;324(7):703. Available from: https://jamanetwork.com/journals/jama/fullarticle/2768533

    Article  CAS  Google Scholar 

  39. Chandrasekaran B, Fernandes S. “Exercise with facemask; Are we handling a devil’s sword?” – a physiological hypothesis. Med Hypotheses [Internet]. 2020;144(June):110002. Available from: https://doi.org/10.1016/j.mehy.2020.110002

    Article  CAS  Google Scholar 

  40. Loke KSH, Tham WY, Bharadwaj P, Keng FYJ, Huang Z, Bin IM, et al. Adapting to a novel disruptive threat: nuclear cardiology service in the time of the coronavirus (COVID-19) outbreak 2020 (SARS REBOOT). J Nucl Cardiol [Internet]. 2020;27(3):1005–9. Available from: https://doi.org/10.1007/s12350-020-02117-0

    Article  Google Scholar 

  41. Wood DA, Mahmud E, Thourani VH, Sathananthan J, Virani A, Poppas A, et al. Safe reintroduction of cardiovascular services during the COVID-19 pandemic: guidance from North American Societies. Can J Cardiol [Internet]. 2020. Available from: https://doi.org/10.1016/j.cjca.2020.04.031

Download references

Author information

Authors and Affiliations

  1. Radiology Department, Hospital Universitário Antônio Pedro – Universidade Federal Fluminense, Niterói, Brazil

    Cláudio Tinoco Mesquita

  2. Nuclear Medicine Department, Hospital Pró-Cardíaco, Rio de Janeiro, Brazil

    Cláudio Tinoco Mesquita

  3. Nuclear Medicine, Hospital Vitória, Rio de Janeiro, Brazil

    Maria Fernanda Rezende

Authors
  1. Cláudio Tinoco Mesquita
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maria Fernanda Rezende
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Cláudio Tinoco Mesquita .

Editor information

Editors and Affiliations

  1. Fluminense Federal University, Niterói, Rio de Janeiro, Brazil

    Cláudio Tinoco Mesquita

  2. Hospital Vitória, Rio de Janeiro, Rio de Janeiro, Brazil

    Maria Fernanda Rezende

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Mesquita, C.T., Rezende, M.F. (2021). Nuclear Cardiology and Coronavirus Disease 2019 (COVID-19) Pandemic. In: Mesquita, C.T., Rezende, M.F. (eds) Nuclear Cardiology. Springer, Cham. https://doi.org/10.1007/978-3-030-62195-7_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-62195-7_9

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-62194-0

  • Online ISBN: 978-3-030-62195-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation